Navigation Links
Breast Cancer Screening in Meghalaya

Cancer is the fastest growing problem in India with nearly 8 lakh fresh cancer cases being reported every year. Meghalaya is no exception //as it has witnessed a sharp rise in the number of cancer cases.

The Health Department conducted a medical camp for breast cancer screening on the National Cancer Awareness day. Breast cancer is rapidly becoming the most prevalent cancer among Indian women followed by cervical cancer.

Addressing a press conference here yesterday, joint director and medical superintendent of Shillong civil hosoital Dr B Garod said, "The number of cancer patients was four in 1989 which went up to 73 in 1993. In 2000, 390 cases were detected and from then every year, we have over 500 patients."

"And this statistics is only for patients treated at the civil hospital here and it excludes cases being treated in other government hospitals in the state," she said.

Lack of awareness among rural people is the core reason responsible for this rapid spread of cancer. In spite of early detection, the rural people fail to come back for treatment until it reaches the advanced stage at which it cannot be cured.

The medical camp conducted breast cancer screening by clinical examination and free ultra sonography. For better access of patients to treatments like radiation therapy (cobalt), chemotherapy, surgery, the Meghalaya state government has established cancer treatment centre at the Shillong civil hospital.

She said, "Cancer treatment centre set up by the state government at Shillong civil hospital is treating 40 patients daily and this arrangement has reduced the number of patients being referred to outside the state for treatment."

Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:

(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: